DXA analysis of a 140-participant subgroup showed that total lean body mass decreased by 9.7% over 68 weeks, while fat mass decreased by 19.3%
It works by mimicking the glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite, slows gastric emptying, and promotes satiety
Reliable temperature control is essential for preserving the medications potency
The effects of long-term HFD consumption on hepatic NF-B activity remain controversial
Scientists went on to test choline, carnitine, and caffeine together, and the results were even more compelling
More participants in the semaglutide group than in the placebo group achieved weight reductions of 5% or more (86% of participants vs 32%), 10% or more (69% vs 12%) and 15% or more (51% vs 5%) at week 68